Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Clinical Videos

Evaluation of Novel Balloon Pulmonary Angioplasty Using Intravascular Ultrasound for Total Occlusion Lesions and Blood Flow in the Postprocedural Phase After Initially Unsuccessful Procedures

08/15/2024

Video 1. Lt. A5b: pulmonary angiography, corresponding to Figure 1A.

Video 2. Lt. A5b: pulmonary angiography, corresponding to Figure 1B.

Video 3. Intravenous ultrasound image, corresponding to Figure 1C.

Video 4. Angiography post-balloon pulmonary angioplasty,  corresponding to Figure 1D.

Video 5. Angiography 2 post-balloon pulmonary angioplasty, corresponding to Figure 1E.

Video 6. Intravenous ultrasound live video, corresponding to Figure 1C and F.

© 2024 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Journal of Invasive Cardiology or HMP Global, their employees, and affiliates.


Advertisement

Advertisement

Advertisement

News

Laser atherectomy
AngioDynamics Announces CE Mark Approval in Europe for the Auryon System
09/10/2024
The technology underlying the Auryon Atherectomy System has been shown in clinical studies to be effective in treating lesions ranging from soft plaque to severely calcified[1-3].
The technology underlying the Auryon Atherectomy System has been shown in clinical studies to be effective in treating lesions ranging from soft plaque to severely calcified[1-3].
The technology underlying the...
09/10/2024
Cath Lab Digest
Rural CV Health
Innovative Delivery, Access to Care Necessary to Increase Health Equity for Rural Patients with Heart Disease
09/10/2024
“Rurality creates unique challenges in delivering high quality cardiovascular care and eliminating health inequities. The ACC Board of Trustees Health Equity Task Force Action Plan outlines implementation strategies that address these...
“Rurality creates unique challenges in delivering high quality cardiovascular care and eliminating health inequities. The ACC Board of Trustees Health Equity Task Force Action Plan outlines implementation strategies that address these...
“Rurality creates unique...
09/10/2024
Cath Lab Digest
Non-Invasive Imaging
Hackensack Meridian Mountainside Medical Center Chosen as One of Six Global Sites for Innovative MICRO 2.0 Clinical Trial
09/10/2024
"The Genetesis MICRO 2.0 trial offers an exciting opportunity to explore non-invasive diagnostic tools to help diagnose microvascular dysfunction that could transform how we approach cardiac care," said Dr. Ankitkumar Patel.
"The Genetesis MICRO 2.0 trial offers an exciting opportunity to explore non-invasive diagnostic tools to help diagnose microvascular dysfunction that could transform how we approach cardiac care," said Dr. Ankitkumar Patel.
"The Genetesis MICRO 2.0 trial...
09/10/2024
Cath Lab Digest
NPO
SCOFF Trial Confirms Fasting Not Needed Before Cath Lab Procedures
09/09/2024
Complications were not increased if patients ate normally before minimally invasive heart procedures under sedation. 
Complications were not increased if patients ate normally before minimally invasive heart procedures under sedation. 
Complications were not increased...
09/09/2024
Cath Lab Digest
Non-Cardiac Surgery
ASSURE DES Trial: No Difference in Ischemic Events if Aspirin Interrupted or Continued in Patients With Coronary Stents Undergoing Non-Cardiac Surgery
09/09/2024
The ASSURE DES trial showed no difference in ischemic events or major bleeding between aspirin monotherapy and no antiplatelet therapy in patients with drug-eluting stent(s) undergoing non-cardiac surgery, with a modest increase in minor...
The ASSURE DES trial showed no difference in ischemic events or major bleeding between aspirin monotherapy and no antiplatelet therapy in patients with drug-eluting stent(s) undergoing non-cardiac surgery, with a modest increase in minor...
The ASSURE DES trial showed no...
09/09/2024
Cath Lab Digest
TAVI
NOTION-3 Trial Investigates How to Manage CAD in Patients Undergoing Valve Implantation
09/09/2024
In the NOTION-3 trial, performing percutaneous coronary intervention (PCI) in patients undergoing transcatheter aortic valve implantation (TAVI) significantly reduced death, myocardial infarction or urgent revascularisation compared with TAVI...
In the NOTION-3 trial, performing percutaneous coronary intervention (PCI) in patients undergoing transcatheter aortic valve implantation (TAVI) significantly reduced death, myocardial infarction or urgent revascularisation compared with TAVI...
In the NOTION-3 trial,...
09/09/2024
Cath Lab Digest
T-TEER
Tri.fr Trial: New Evidence for Benefits of Transcatheter Edge-to-Edge Repair in Secondary Tricuspid Regurgitation
09/09/2024
In the Tri.fr trial, tricuspid transcatheter edge-to-edge repair (T-TEER) plus optimal medical therapy resulted in a significant improvement of the primary endpoint including death, cardiovascular hospitalisation, functional class and...
In the Tri.fr trial, tricuspid transcatheter edge-to-edge repair (T-TEER) plus optimal medical therapy resulted in a significant improvement of the primary endpoint including death, cardiovascular hospitalisation, functional class and...
In the Tri.fr trial, tricuspid...
09/09/2024
Cath Lab Digest
MEETINGS
ACC Quality Summit Highlights Critical Value of ACC Accreditation and NCDR Services
09/06/2024
The American College of Cardiology (ACC) Quality Summit 2024 will take place on September 17-19 in San Antonio, bringing together cardiovascular leaders from across the nation to discuss the value of NCDR services and quality programs.
The American College of Cardiology (ACC) Quality Summit 2024 will take place on September 17-19 in San Antonio, bringing together cardiovascular leaders from across the nation to discuss the value of NCDR services and quality programs.
The American College of...
09/06/2024
Cath Lab Digest
TAVR
Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study
09/06/2024
Venus-Vitae utilizes the Venus-Endura technology, which integrates multiple anti-calcification techniques, immunogenicity removal technology and 3D force-controlled dehydration technology, providing exceptional durability, biocompatibility,...
Venus-Vitae utilizes the Venus-Endura technology, which integrates multiple anti-calcification techniques, immunogenicity removal technology and 3D force-controlled dehydration technology, providing exceptional durability, biocompatibility,...
Venus-Vitae utilizes the...
09/06/2024
Cath Lab Digest
Risk Factors
Chinese American Immigrants Face Higher Risk of Cardiovascular Disease Depending on Length of Residence and Location in the U.S. 
09/05/2024
The study observed the heart health of 746 Chinese Americans in both Los Angeles and Chicago over a period of roughly 18 years. Participants who resided in Chicago showed lower mortality levels from heart disease compared to those who lived...
The study observed the heart health of 746 Chinese Americans in both Los Angeles and Chicago over a period of roughly 18 years. Participants who resided in Chicago showed lower mortality levels from heart disease compared to those who lived...
The study observed the heart...
09/05/2024
Cath Lab Digest

Advertisement

Advertisement

Laser atherectomy
AngioDynamics Announces CE Mark Approval in Europe for the Auryon System
09/10/2024
The technology underlying the Auryon Atherectomy System has been shown in clinical studies to be effective in treating lesions ranging from soft plaque to severely calcified[1-3].
The technology underlying the Auryon Atherectomy System has been shown in clinical studies to be effective in treating lesions ranging from soft plaque to severely calcified[1-3].
The technology underlying the...
09/10/2024
Cath Lab Digest
Rural CV Health
Innovative Delivery, Access to Care Necessary to Increase Health Equity for Rural Patients with Heart Disease
09/10/2024
“Rurality creates unique challenges in delivering high quality cardiovascular care and eliminating health inequities. The ACC Board of Trustees Health Equity Task Force Action Plan outlines implementation strategies that address these...
“Rurality creates unique challenges in delivering high quality cardiovascular care and eliminating health inequities. The ACC Board of Trustees Health Equity Task Force Action Plan outlines implementation strategies that address these...
“Rurality creates unique...
09/10/2024
Cath Lab Digest
Non-Invasive Imaging
Hackensack Meridian Mountainside Medical Center Chosen as One of Six Global Sites for Innovative MICRO 2.0 Clinical Trial
09/10/2024
"The Genetesis MICRO 2.0 trial offers an exciting opportunity to explore non-invasive diagnostic tools to help diagnose microvascular dysfunction that could transform how we approach cardiac care," said Dr. Ankitkumar Patel.
"The Genetesis MICRO 2.0 trial offers an exciting opportunity to explore non-invasive diagnostic tools to help diagnose microvascular dysfunction that could transform how we approach cardiac care," said Dr. Ankitkumar Patel.
"The Genetesis MICRO 2.0 trial...
09/10/2024
Cath Lab Digest
NPO
SCOFF Trial Confirms Fasting Not Needed Before Cath Lab Procedures
09/09/2024
Complications were not increased if patients ate normally before minimally invasive heart procedures under sedation. 
Complications were not increased if patients ate normally before minimally invasive heart procedures under sedation. 
Complications were not increased...
09/09/2024
Cath Lab Digest
Non-Cardiac Surgery
ASSURE DES Trial: No Difference in Ischemic Events if Aspirin Interrupted or Continued in Patients With Coronary Stents Undergoing Non-Cardiac Surgery
09/09/2024
The ASSURE DES trial showed no difference in ischemic events or major bleeding between aspirin monotherapy and no antiplatelet therapy in patients with drug-eluting stent(s) undergoing non-cardiac surgery, with a modest increase in minor...
The ASSURE DES trial showed no difference in ischemic events or major bleeding between aspirin monotherapy and no antiplatelet therapy in patients with drug-eluting stent(s) undergoing non-cardiac surgery, with a modest increase in minor...
The ASSURE DES trial showed no...
09/09/2024
Cath Lab Digest
TAVI
NOTION-3 Trial Investigates How to Manage CAD in Patients Undergoing Valve Implantation
09/09/2024
In the NOTION-3 trial, performing percutaneous coronary intervention (PCI) in patients undergoing transcatheter aortic valve implantation (TAVI) significantly reduced death, myocardial infarction or urgent revascularisation compared with TAVI...
In the NOTION-3 trial, performing percutaneous coronary intervention (PCI) in patients undergoing transcatheter aortic valve implantation (TAVI) significantly reduced death, myocardial infarction or urgent revascularisation compared with TAVI...
In the NOTION-3 trial,...
09/09/2024
Cath Lab Digest
T-TEER
Tri.fr Trial: New Evidence for Benefits of Transcatheter Edge-to-Edge Repair in Secondary Tricuspid Regurgitation
09/09/2024
In the Tri.fr trial, tricuspid transcatheter edge-to-edge repair (T-TEER) plus optimal medical therapy resulted in a significant improvement of the primary endpoint including death, cardiovascular hospitalisation, functional class and...
In the Tri.fr trial, tricuspid transcatheter edge-to-edge repair (T-TEER) plus optimal medical therapy resulted in a significant improvement of the primary endpoint including death, cardiovascular hospitalisation, functional class and...
In the Tri.fr trial, tricuspid...
09/09/2024
Cath Lab Digest
MEETINGS
ACC Quality Summit Highlights Critical Value of ACC Accreditation and NCDR Services
09/06/2024
The American College of Cardiology (ACC) Quality Summit 2024 will take place on September 17-19 in San Antonio, bringing together cardiovascular leaders from across the nation to discuss the value of NCDR services and quality programs.
The American College of Cardiology (ACC) Quality Summit 2024 will take place on September 17-19 in San Antonio, bringing together cardiovascular leaders from across the nation to discuss the value of NCDR services and quality programs.
The American College of...
09/06/2024
Cath Lab Digest
TAVR
Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study
09/06/2024
Venus-Vitae utilizes the Venus-Endura technology, which integrates multiple anti-calcification techniques, immunogenicity removal technology and 3D force-controlled dehydration technology, providing exceptional durability, biocompatibility,...
Venus-Vitae utilizes the Venus-Endura technology, which integrates multiple anti-calcification techniques, immunogenicity removal technology and 3D force-controlled dehydration technology, providing exceptional durability, biocompatibility,...
Venus-Vitae utilizes the...
09/06/2024
Cath Lab Digest
Risk Factors
Chinese American Immigrants Face Higher Risk of Cardiovascular Disease Depending on Length of Residence and Location in the U.S. 
09/05/2024
The study observed the heart health of 746 Chinese Americans in both Los Angeles and Chicago over a period of roughly 18 years. Participants who resided in Chicago showed lower mortality levels from heart disease compared to those who lived...
The study observed the heart health of 746 Chinese Americans in both Los Angeles and Chicago over a period of roughly 18 years. Participants who resided in Chicago showed lower mortality levels from heart disease compared to those who lived...
The study observed the heart...
09/05/2024
Cath Lab Digest

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement